Bolt Biotherapeutics, Inc. (BOLT) NASDAQ

5.24

-0.03(-0.57%)

Updated at December 04 03:29PM

Currency In USD

Valuation

Market Cap408.57M
Enterprise Value426.57M
P/E Ratio-0.24
PEG Ratio0
Price/Sales Ratio0.35
Price/Book Ratio0.32
Enterprise/Revenue0.55
Enterprise/EBITDA-0.37

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-1.46
Operating Margin-1.57

Management Effectiveness

Return On Assets-0.66
Return On Equity-0.98

Income Statement

Revenue7.69M
Revenue/Share15.26
Gross Profit7.69M
EBITDA-66.46M
Net Income-63.12M
Diluted EPS-1.65

Balance Sheet

Total Cash31.91M
Total Cash/Share16.62
Total Debt23.59M
Total Debt/Equity0.73
Current Ratio3.57
Book Value Per Share16.72

Price History

52-Week Change-53.63
52-Week High12.6
52-Week Low4.41
Moving Average 50 Days5.35
Moving Average 200 Days6.31

Statistics

Average Volume29,519
Shares Outstanding1.92M
% Held by Institutions41.93

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:20
Last Split DateJune 09, 2025